本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

577.30
-8.9100-1.52%
成交量:22.09万
成交额:1.28亿
市值:131.11亿
市盈率:-44.29
高:593.00
开:585.39
低:573.00
收:586.21
52周最高:605.00
52周最低:265.00
股本:2,271.14万
流通股本:1,100.01万
量比:0.93
换手率:2.01%
股息:- -
股息率:- -
每股收益(TTM):-13.0355
每股收益(LYR):-21.9007
净资产收益率:-41.22%
总资产收益率:-15.78%
市净率:20.95
市盈率(LYR):-26.36

数据加载中...

2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors